CNSP News and Press, CNS Pharmaceuticals Inc. From 02/01/22

New research has found that the combined use of radiation and IL-7 (interleukin 7), which is an immune-boosting protein, improves survival rates for mice with glioblastoma. Glioblastoma is a cancer that occurs in an individual’s spinal cord or brain. The conventional treatment for...

VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (the “Company” or “WPD”) (CSE: WBIO) (FSE: 8SV1), announced that in respect to its sublicense agreement with CNS Pharmaceuticals, Inc. (the “CNS Agre...

PTSD and traumatic brain injuries are the primary indications affecting veterans, with almost 500,000 troops living with these diseases. However, thousands more have also been diagnosed as having illnesses that may be connected to toxic waste and environmental hazards. Hundreds of vetera...

Brain tumors are noncancerous or cancerous masses or growths of abnormal cells in the brain. Brain cancer usually originates in the central nervous system , which is made up of the spinal cord and the brain. Over the last 10 years, this serious and often debilitating ailment has been discus...

CNS Pharmaceuticals received approval from swissethics for its potentially pivotal study of Berubicin, a novel anthracycline for the treatment of Glioblastoma Multiforme (“GBM”) The approval is the first from a European Ethics Committee The company, which dosed the first...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”), today announced that its CEO John Climaco will participate in the Virtual I...

CNS Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conference Live video webcast presentation on Wednesday, January 26th at 11:00 AM ET PR Newswire HOUSTON , Jan. 20, 2022 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("C...

A new study conducted by researchers at the Brain Tumor Research Center at the University of Plymouth has found that the drugs used to treat HIV and AIDS may be effective in the treatment of low-grade brain tumors. The study’s researchers believe that ARVs could be prescribed for pa...

- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ / ACCESSWIRE / January 12, 2022 / JTC Team ("JTC"), a fully integrate...

CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has closed on its previously announced private placement. The company announced that the placement...